US-based Shine Medical Technologies, a nuclear technology company focused on becoming a leading producer of medical isotopes, has closed $80m in Series C financing for work on a production facility.
The Wisconsin company, founded in 2010, said Fidelity Management and Research Company was the largest investor in the round, which also included participation from other new investors and the company’s current investors.
Series C financing is one of the stages in the one of the stages in the capital-raising process. Businesses that make it to Series C funding are already reasonably successful and looking for additional funding to help them develop new products, expand into new markets, or even to acquire other companies.
The Wisconsin company, founded in 2010, said Fidelity Management and Research Company was the largest investor in the round, which also included participation from other new investors and the company’s current investors.
Series C financing is one of the stages in the one of the stages in the capital-raising process. Businesses that make it to Series C funding are already reasonably successful and looking for additional funding to help them develop new products, expand into new markets, or even to acquire other companies.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
